{
    "nctId": "NCT06498154",
    "briefTitle": "Eliminating Breast Surgery for Breast Cancer Patients With Clinical Complete Response to Neoadjuvant Systemic Therapy",
    "officialTitle": "Eliminating Breast Surgery for Triple Negative or HR-/HER2+ Breast Cancer Patients With Clinical Complete Response to Combined Neoadjuvant Chemotherapy and Neoadjuvant Radiotherapy: A Multicenter, Phase 2 Trial (EBCS)",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "5-year EFS",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female initial treatment patients aged \u2265 18 years and \u2264 70 years old\n* ECOG score 0-1\n* Clinical T1-2N0 HER2 positive ( HR negative HER2 IHC score of 3+, or 2+and ISH test positive) or triple negative invasive breast cancer\n* Left ventricular ejection fraction (LVEF) \u2265 50%\n* 12 lead electrocardiogram: QT interval (QTcF) corrected by Fridericia method for females\\<470ms\n* The functional level of the main organs must meet the following requirements: blood routine: ANC \u2265 1.5 \u00d7 109/L# PLT\u226590 \u00d7 109/L# Hb\u226590 g/L#Blood biochemistry: TBIL \u2264 2.5 \u00d7 ULN# ALT and AST \u2264 2.5 \u00d7 ULN# BUN and Cr \u2264 1.5 \u00d7 ULN#\n* For female subjects who have not undergone menopause or surgical sterilization, during the treatment period and during the study treatment\n* Agree to abstain or use effective contraceptive methods for at least 2 months after the next administration; .Volunteer to join this study, sign informed consent, have good compliance, and be willing to cooperate with follow-up.\n\nExclusion Criteria:\n\n* Inflammatory breast cancer\n* Metastatic tumor\n* Previous or concurrent malignant tumors, whose natural history or treatment may interfere with the safety of the research protocol.\n* Active infections that require systemic treatment\n* Has used any medication in this study within 14 days prior to enrollment\n* Major surgery (excluding biopsy) performed within 14 days before enrollment",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}